Annual report pursuant to Section 13 and 15(d)

DERIVATIVE LIABILITY (Details Narrative)

v3.24.0.1
DERIVATIVE LIABILITY (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Jul. 28, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Derivative Liability, Fair Value $ 39,450 $ 36,868  
Gain (Loss) on Sale of Derivatives $ (2,582) $ 96,842  
Probability of decreased repayment of loan 10.00% 35.00%  
Probability of increased in repayment of loan 40.00% 55.00%  
Loan Agreement [Member] | K2 HealthVentures LLC [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Secured debt $ 17,893,738    
Derivative Liability, Fair Value 39,450 $ 36,868  
Gain (Loss) on Sale of Derivatives $ 2,582    
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Share-based Payment Arrangement, Tranche One [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Secured debt     $ 20,000,000